- ADJUNCT PROFESSOR Ophthalmology
- Dr. John Danias is currently practicing part-time clinical ophthalmology with part-time involvement in basic research.
Dr. Danias received his M.D. in Greece at the University of Athens Medical School, where he then achieved a Ph.D. in Histology and Embryology. He completed his ophthalmology residency at the Naval Hospital of Athens. Upon moving to the United States, he did his internship in Internal Medicine at Lenox Hill Hospital in New York City and stayed in New York completing his ophthalmology residency and glaucoma fellowship at the Mount Sinai Medical Center. Dr. Danias is a Diplomate of the American Board of Ophthalmology.
Dr. Danias is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and of the Athens Medical Association. A devoted researcher, he is currently investigating the role of glutamate in the pathophysiology of glaucoma. His numerous published articles and chapters explore the effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma, methods of detecting progression of optic nerve head damage in advanced glaucoma, and the effective use of topically administered hyperosmotic agents in patients with corneal edema secondary to acute glaucoma. Dr. Danias is also involved in developing the use of the ultrasound biomicroscope (UBM), a non-invasive method to achieve high resolution imaging of the anterior segment of the eye. The UBM is useful in certain cases of glaucoma, for imaging lesions present behind the iris and for imaging behind a cloudy cornea that could not otherwise be viewed by external examination.In the News
Dr. Danias and his work diagnosing and managing glaucoma were recently profiled in The Daily News feature The Daily Check Up. View the PDF.
ResearchDr. Danias's research focuses on the role of glutamate in the pathophysiology of glaucoma.
Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie S, Danias J, Bronstein JM, Kachar B, Lazzarini R. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 1999 Dec 10; 99(6): 649-59.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Danias did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 22 Room 24
1468 Madison Avenue
New York, NY 10029